We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.
company profile
SECTOR
industry
Exchange
County of HQ
Next Earnings Date
Business Summary
VALUATION
P/E
N/A
Market Cap ($M USD)
$744.16M
Forward P/E
N/A
PEG
N/A
PRICE TO SALES
N/A
PRICE TO BOOK
N/A
EV / EBITDA
N/A
5-Year Average P/E
Free Cash Flow Yield
N/A
DCF Value
N/A
Graham Number
N/A
Price to FCF
N/A
EV to FCF
N/A
Earnings Yield
N/A
FCF Yield
N/A
DIVIDEND
Yield
Annual Payout
Payout Ratio
Consecutive Years of Dividend Growth
5-Year Dividend Growth Rate
Financial Health & Profitability
Earnings Per Share
Next Year EPS Growth Estimate
N/A
Next Year Revenue Growth Estimate
N/A
Return on Equity (ROE)
N/A
FREE CASH FLOW
Operating Margin
N/A
Debt-to-Equity
N/A
Piotroski F-Score
N/A
Altman Z-Score
N/A
Return on Invested Capital (ROIC)
N/A
Current Ratio
N/A
Quick Ratio
N/A
Net Debt to EBITDA
N/A
Interest Coverage
N/A
Gross Profit margin
N/A
FCF PER SHARE
N/A
REVENUE PER SHARE
N/A
Gainseekers Quantitative Analysis
Summary
The market seems to be navigating in the dark with MSOS AdvisorShares Pure US Cannabis ETF. With a snapshot price that has recently been extended above its 50-Day and 200-Day SMAs, the stock appears technically overextended. The absence of critical valuation metrics like Forward P/E, Earnings Yield, and Altman Z-score leaves investors without a clear picture of its safety and growth potential. The lack of a DCF Value and Graham Number further complicates any definitive valuation assessment. This ETF is a puzzle with missing pieces, making it a risky proposition for those seeking clarity and stability.
AI Exposure / Tech Reliance
The Bull Case
For a value or GARP investor, the allure of MSOS might be its potential for growth in the burgeoning cannabis sector. However, without concrete metrics like ROIC, FCF Yield, or Piotroski F-Score, it's challenging to craft a compelling narrative about its pricing power or capital efficiency. The ETF's appeal lies more in the sector's promise than in its current financial metrics.
The Bear Case
The glaring absence of key financial metrics is the Achilles' heel of MSOS. With no data on Price/Book, Price/Sales, or cash flow, investors are left in the dark about its valuation and liquidity. The stock's proximity to its 52-week high suggests a technical overextension, raising concerns about its current pricing. This lack of transparency and potential overvaluation could deter risk-averse investors.
Market Sentiment & Smart Money
Short Interest %
Analyst Consensus
N/A
Average Analyst Price Target
N/A
Institutional Ownership %
1-Year Beta
0.87
Insider Buying % (6 Mo)
Distance to 52-Week High
41.60%
Distance to 52-Week Low
59.77%
EARNINGS SURPRISE %
N/A
50-DAY SMA
$4.34
200-DAY SMA
$4.41
⚠️ Financial Disclaimer: This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.